E/M Coding Alert - 2003 Issue 20
CMS Expands Coverage for Lung Surgery
Subscribe or sign in to view the full article.
Article Overview
This article reviews a set of CMS coverage actions and reconsiderations spanning laboratory testing, pulmonary surgery, cardiac device coverage in clinical trials, oncology therapy reviews, and an eye-treatment policy reconsideration. It is relevant to coders, compliance staff, reimbursement analysts, and clinicians who monitor Medicare coverage changes and public comment opportunities. The discussion provides a broad overview of the policy topics involved and the areas of Medicare coverage affected.
Why This Topic Matters
CMS coverage updates can affect whether services are payable, whether diagnostic criteria are recognized, and whether coverage is being reconsidered through national processes or advisory review. Organizations that bill Medicare need to track these changes because they can influence documentation, claims handling, and participation in public comment processes.
Article Sections
-
Laboratory services coverage correction
This section discusses a correction to a prior CMS coverage issue involving laboratory testing policy and diagnosis inclusion. It also notes an expanded coverage concept related to atherosclerotic disease risk.
-
Lung volume reduction surgery decision memorandum
This section summarizes CMS coverage action on lung surgery and distinguishes between covered and noncovered patient groups under the review. It places the policy in the context of emphysema and national coverage evaluation.
-
Coverage process for coagulation testing
This section covers a new CMS review concerning two clotting-related laboratory procedures and public comment on diagnosis coverage. It highlights a specific mismatch between narrative indications and the codes under review.
-
Automatic implantable cardiac defibrillators
This section notes a reopened CMS coverage process for implantable cardiac defibrillators in connection with national clinical trials. It indicates that the topic is being reconsidered within a formal coverage framework.
-
Radioimmunotherapy for non-Hodgkin's lymphoma
This section describes a reopened comment period on oncology coverage review for radioimmunotherapy and related therapies. It focuses on CMS reconsideration of selected uses of these treatments.
-
Ocular photo-dynamic therapy reconsideration
This section explains that CMS is reconsidering a prior national noncoverage determination for an eye treatment and that the issue will be reviewed by a Medicare advisory body. It references the policy history and the ongoing reconsideration process.
What You Will Learn
- How CMS coverage corrections can affect Medicare policy status
- What general types of services and therapies are under review in the article
- How public comment and reconsideration processes fit into CMS coverage actions
- Which broad clinical areas are involved in the coverage updates
Who Should Read This
- Medical coders
- Revenue cycle professionals
- Compliance officers
- Healthcare administrators
- Physicians and clinical staff
- Medicare policy analysts
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com